Atlas Trials

Ivermectin-artemisinin Combination Therapy for Eradication of Malaria

Clinical trial NCT05605925 · UNKNOWN

Trial details

NCT number
NCT05605925
Sponsor
Makerere University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Malaria
Start date
2022-08-04
Primary completion
2022-12-31
Enrollment
138

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.